Clinical Trials for Editas Medicine

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Editas Medicine

Clinical Trials (3)

NCT06363760
A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301
N/AEnrolling by invitation
54 participants
Started: Jun 17, 2024 · Completed: Aug 31, 2040
3 conditions1 sponsor18 locations
NCT05444894
EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT)
PHASE1/PHASE2Active, not recruiting
9 participants
Started: Apr 29, 2022 · Completed: Dec 31, 2025
4 conditions1 sponsor8 locations
NCT04853576
A Study Evaluating the Safety and Efficacy of EDIT-301 in Participants With Severe Sickle Cell Disease (RUBY)
PHASE1/PHASE2Active, not recruiting
45 participants
Started: May 4, 2021 · Completed: Aug 31, 2025
2 conditions1 sponsor24 locations